Page 49 - Read Online
P. 49

Jain et al. Rare Dis Orphan Drugs J 2024;3:8  https://dx.doi.org/10.20517/rdodj.2023.42  Page 9 of 9

                   2023. Available from: https://www.aph.gov.au/Parliamentary_Business/Committees/House/Health_Aged_Care_and_Sport/Newdrugs/
                   Government_Response [Last accessed on 28 Feb 2024].
               46.      Ministry of Health and Welfare. The Rare disease and orphan drug act. 2015. Available from: https://law.moj.gov.tw/ENG/LawClass/
                   LawAll.aspx?pcode=L0030003 [Last accessed on 28 Feb 2024].
               47.      Hsiang NC, Huang WF, Gau CS, Tsai TW, Chang LC. The impact of the rare disease and orphan drug act in Taiwan. J Food Drug
                   Anal 2021;29:717-25.  DOI  PubMed  PMC
               48.      Adachi T, El-Hattab AW, Jain R, et al. Enhancing equitable access to rare disease diagnosis and treatment around the world: a review
                   of evidence, policies, and challenges. Int J Environ Res Public Health 2023;20:4732.  DOI  PubMed  PMC
               49.      LCQ20: policies and measures on rare diseases. Available from: https://www.info.gov.hk/gia/general/202105/05/P2021050500461.htm
                   [Last accessed on 28 Feb 2024].
               50.      Chung CCY, Ng NYT, Ng YNC, et al. Socio-economic costs of rare diseases and the risk of financial hardship: a cross-sectional study.
                   Lancet Reg Health West Pac 2023;34:100711.  DOI  PubMed  PMC
               51.      Orphan Drugs & Rare Diseases. Drew & Napier/Singapore. Available from: https://pharmaboardroom.com/legal-articles/orphan-
                   drugs-rare-diseases-singapore/ [Last accessed on 28 Feb 2024].
               52.      Minister for Health. Singaporeans diagnosed with rare diseases and coverage by rare disease fund. 2023. Available from: https://www.
                   moh.gov.sg/news-highlights/details/singaporeans-diagnosed-with-rare-diseases-and-coverage-by-rare-disease-fund [Last accessed on
                   28 Feb 2024].
               53.      Rare Disease Fund. What is the rare disease fund? Available from: https://www.kkh.com.sg/giving/Documents/Rare-Disease-Fund/
                   index.html [Last accessed on 28 Feb 2024].
               54.      Agency for Care Effectiveness. Drug and vaccine evaluation methods and process guide. 2023. Available from: https://www.ace-hta.
                   gov.sg/docs/default-source/process-methods/drug-and-vaccine-evaluation-methods-and-process-guide-version-3-1-(september-2023).
                   pdf [Last accessed on 28 Feb 2024].
               55.      Pae Ora (healthy futures) bill. Government bill 85-3. 2021. Available from: https://legislation.govt.nz/bill/government/2021/0085/
                   latest/whole.html#LMS575405 [Last accessed on 28 Feb 2024].
               56.      Priority lists for funding applications. Available from: https://pharmac.govt.nz/medicine-funding-and-supply/the-funding-process/
                   priority-lists [Last accessed on 28 Feb 2024].
               57.      Funding for rare disorders. Available from: https://pharmac.govt.nz/medicine-funding-and-supply/the-funding-process/from-
                   application-to-funded-medicine-how-we-fund-a-medicine/medicines-for-rare-disorders [Last accessed on 28 Feb 2024].
               58.      The Pharmac Review. Available from: https://pharmac.govt.nz/about/pharmacreview [Last accessed on 28 Feb 2024].
               59.      New Zealand Health Strategy. 2023. Available from: https://www.health.govt.nz/publication/new-zealand-health-strategy [Last
                   accessed on 28 Feb 2024].
               60.      Provisional Health of Disabled People Strategy. 2023. Available from: https://www.health.govt.nz/publication/provisional-health-
                   disabled-people-strategy [Last accessed on 28 Feb 2024].
               61.      Rare Disorders New Zealand. Rare support centre aotearoa. 2023. Available from: https://www.raredisorders.org.nz/assets/Documents/
                   RSCA-centre-of-expertise-131123-v2.pdf [Last accessed on 28 Feb 2024].
               62.      Chung CCY, Ng YNC, Jain R, Chung BHY. A thematic study: impact of COVID-19 pandemic on rare disease organisations and
                   patients across ten jurisdictions in the Asia Pacific region. Orphanet J Rare Dis 2021;16:119.  DOI  PubMed  PMC
               63.      Chung CC, Wong WH, Fung JL, Hong Kong RD, Chung BH. Impact of COVID-19 pandemic on patients with rare disease in Hong
                   Kong. Eur J Med Genet 2020;63:104062.  DOI  PubMed  PMC
               64.      Padilla CD, Therrell BL Jr, Alcausin MMLB, et al. Successful implementation of expanded newborn screening in the Philippines using
                   tandem mass spectrometry. Int J Neonatal Screen 2022;8:8.  DOI  PubMed  PMC
               65.      Political declaration of the high-level meeting on universal health coverage. Universal health coverage: moving together to build a
                   healthier  world.  Available  from:  https://www.un.org/pga/73/wp-content/uploads/sites/53/2019/07/FINAL-draft-UHC-Political-
                   Declaration.pdf [Last accessed on 28 Feb 2024].
               66.      UN. General Assembly (76th sess.: 2021-2022). Addressing the challenges of persons living with a rare disease and their families:
                   resolution/adopted by the general assembly. 2021. Available from: https://digitallibrary.un.org/record/3953765?ln+=+en&ln=ar [Last
                   accessed on 28 Feb 2024].
   44   45   46   47   48   49   50   51   52   53   54